Evidence Synthesis
IRISDOREME Sees Strong Shift in Key Metrics, With Gross Margin Accelerating to 40.96%, Marginal Operating Leverage Rising to 13.15%, and Daily Volume Increasing to 2,431,238 shares.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 6 Sept 2026, 04:23
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
IRISDOREME Sees Strong Shift in Key Metrics, With Gross Margin Accelerating to 40.96%, Marginal Operating Leverage Rising to 13.15%, and Daily Volume Increasing to 2,431,238 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 40.96 % | 13.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 13.15 % | 8.76 | ▲ |
| REVENUE_GROWTH_YOY | 26.3 % | 50 | ▼ |
| PRICE_CHANGE_PERCENT | 6.369 % | — | - |
| DAILY_VOLUME | 24,31,238 shares | 10,00,789 | ▲ |
| CLOSE_PRICE | 63.8 INR | 59.98 | ▲ |